Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-20
2007-11-20
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S186000, C546S187000, C546S188000
Reexamination Certificate
active
11456589
ABSTRACT:
Compounds of formula (I)in which R, R1, R2, n and X1have the meanings given in the specification are Factor Xa inhibitors useful in the treatment of thrombotic disorders.
REFERENCES:
patent: 6262069 (2001-07-01), Liebeschuetz et al.
patent: 6521609 (2003-02-01), Doods et al.
patent: 6855715 (2005-02-01), Liebeschuetz et al.
patent: 6900196 (2005-05-01), Liebeschuetz et al.
patent: 2004/0254374 (2004-12-01), Jones et al.
patent: 2005/0026928 (2005-02-01), Wiley et al.
patent: WO 99/11657 (1999-03-01), None
patent: WO 99/11658 (1999-03-01), None
patent: WO 00/71493 (2000-11-01), None
patent: WO 00/76971 (2000-12-01), None
patent: WO 01/96323 (2001-12-01), None
Jones, Stuart D, et al., Bioorganic & Medicinal Chemistry Letters 11 (2001) 733-736.
Bastian Jolie Anne
Murray Christopher William
Sall Daniel Jon
Wiley Michael Robert
Young Stephen Clinton
Anderson Rebecca
Chung Susannah
Eli Lilly and Company
Jackson Thomas E.
LandOfFree
Certain glycine derivatives as factor Xa inhibitors for use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain glycine derivatives as factor Xa inhibitors for use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain glycine derivatives as factor Xa inhibitors for use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3875577